Loading...
XJPX
7777
Market cap118mUSD
Jun 12, Last price  
154.00JPY
1D
-2.53%
1Q
13.24%
Jan 2017
-76.09%
IPO
-58.41%
Name

3-D Matrix Ltd

Chart & Performance

D1W1MN
P/E
—
P/S
3.70
EPS
—
Div Yield, %
—
Shrs. gr., 5y
22.82%
Rev. gr., 5y
69.41%
Revenues
4.59b
+98.30%
158,320,0001,107,387,00032,013,000107,160,00099,776,000141,834,000615,852,000228,615,000328,847,000672,418,0001,024,375,0001,506,230,0002,314,083,0004,588,818,000
Net income
-256m
L-89.55%
-533,952,000308,610,000-978,331,000-1,525,374,000-1,994,965,000-2,459,327,000-1,392,571,000-1,866,217,000-2,554,559,000-3,096,159,000-2,012,615,000-1,894,757,000-2,445,978,000-255,505,000
CFO
-1.90b
L-58.56%
-433,762,000-131,013,000-655,715,000-1,679,990,000-1,904,814,000-1,463,852,000-1,887,017,000-2,020,656,000-2,301,529,000-2,189,247,000-3,249,736,000-2,903,268,000-4,585,082,000-1,899,876,000

Profile

3-D Matrix, Ltd. develops self-assembling peptide technology. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the fields of regenerative medicine, cell therapy, drug delivery technology, and surgical treatment. The company was founded in 2004 and is based in Tokyo, Japan.
URL
https://www.3d-matrix.co.jp/
IPO date
Oct 24, 2011
Employees
108
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑042023‑042022‑042021‑042020‑042019‑042018‑042017‑042016‑04
Income
Revenues
4,588,818
98.30%
2,314,083
53.63%
Cost of revenue
6,705,856
5,472,427
Unusual Expense (Income)
NOPBT
(2,117,038)
(3,158,344)
NOPBT Margin
Operating Taxes
230,873
2,104
Tax Rate
NOPAT
(2,347,911)
(3,160,448)
Net income
(255,505)
-89.55%
(2,445,978)
29.09%
Dividends
Dividend yield
Proceeds from repurchase of equity
2,246,690
304,100
BB yield
-25.55%
-3.22%
Debt
Debt current
300,000
500,000
Long-term debt
3,873,820
3,873,820
Deferred revenue
Other long-term liabilities
122,303
124,030
Net debt
2,801,877
3,044,917
Cash flow
Cash from operating activities
(1,899,876)
(4,585,082)
CAPEX
(29,051)
(18,705)
Cash from investing activities
(29,758)
(81,504)
Cash from financing activities
2,062,563
2,955,543
FCF
(2,179,633)
(4,567,322)
Balance
Cash
1,363,538
1,170,903
Long term investments
8,405
158,000
Excess cash
1,142,502
1,213,199
Stockholders' equity
(9,945,785)
(10,833,354)
Invested Capital
14,595,216
15,783,246
ROIC
ROCE
EV
Common stock shares outstanding
73,288
60,191
Price
120.00
-23.57%
157.00
-54.62%
Market cap
8,794,566
-6.94%
9,450,039
-46.38%
EV
11,596,443
13,801,782
EBITDA
(2,117,038)
(3,158,344)
EV/EBITDA
Interest
83,764
60,563
Interest/NOPBT